Vantage Issues Synopsis of the FDA's Guidance on Grandfathering for the Drug Supply Chain Security Act

Tuesday, December 5, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Provides timing, recommendations for pharmaceutical manufacturers, distributors and repackagers

HILLSBOROUGH, N.J., Dec. 5, 2017 /PRNewswire/ -- Vantage Consulting Group, a trusted manufacturing automation expert,

today announced it has published an interpretation and summary of the recent guidance with regards to 'grandfathering' under the Food and Drug Administration's (FDA) Drug Supply Chain Security Act (DSCSA). The DSCSA outlines steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States, enhancing the FDA's ability to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful.

"The DSCSA will make pharmaceuticals safer for consumers, but complying with the act has been a very intense and expensive undertaking for the industry," said John Jordon, vice president, Business Strategies, Vantage Consulting Group. "With the upcoming packaging-based deadlines, we hope the synopsis unveiled in this paper will help companies understand what needs to be done, when and how it is documented."

The paper, which can be downloaded at https://www.vantage-cg.com/professional-development-series/, outlines trading partner requirements under grandfathering for manufacturers, distributors, dispensers and re-packagers. It also features guidance on product implications and saleable returns.

About Vantage Consulting GroupVantage Consulting Group is a focused manufacturing solutions provider helping pharmaceutical and food companies deliver safer, higher quality products. It solves complex manufacturing automation problems ? including vision inspection, serialization and packaging ? by providing end-to-end expertise that spans strategic guidance, design, implementation and validation. Capital projects are consistently delivered more effectively, quickly and at less cost because of the company's deep industry expertise and proven methodology. Headquartered in Hillsborough, NJ, Vantage also operates centers of excellence in Berlin, Germany and San Juan, Puerto Rico. For more information, please visit www.vantage-cg.com.

View original content:http://www.prnewswire.com/news-releases/vantage-issues-synopsis-of-the-fdas-guidance-on-grandfathering-for-the-drug-supply-chain-security-act-300566680.html

SOURCE Vantage Consulting Group



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store